Arrowhead Pharmaceuticals, Inc. (ARWR) on GreekSoup https://greeksoup.ai/stocks/us/arwr/ Every dated entry in the public record on Arrowhead Pharmaceuticals, Inc.: results, filings, insider trades and the rest, from the filings, the last 90 days. en Fri, 09 Oct 2026 00:00:00 +0000 Arrowhead Pharmaceuticals, Inc.: short interest 9,272,290 shares at the 15 September 2026 settlement, 5.15 days to coverhttps://greeksoup.ai/stocks/us/arwr/short-interest/us:ARWR:short-interest:2026-09-15:ed8c1351afTue, 15 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Arrowhead Pharmaceuticals, Inc.: short interest 9,426,449 shares at the 31 August 2026 settlement, 8.81 days to coverhttps://greeksoup.ai/stocks/us/arwr/short-interest/us:ARWR:short-interest:2026-08-31:4f92affa80Mon, 31 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Arrowhead Pharmaceuticals, Inc.: Olukotun Adeoye Y (Director) sold 2,000 shares at $86.96 on 18 August 2026, $173,920https://greeksoup.ai/stocks/us/arwr/insiders/us:ARWR:insider:2026-08-20:7821f2f033Thu, 20 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Arrowhead Pharmaceuticals, Inc.: Perry Michael S (Director) sold 11,600 shares at $87.30 on 18 August 2026, $1.0 millionhttps://greeksoup.ai/stocks/us/arwr/insiders/us:ARWR:insider:2026-08-20:5ddbc9c823Thu, 20 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Arrowhead Pharmaceuticals, Inc.: Form 144, Adeoye Olukotun plans to sell 2,000 shares worth $173,876 around 18 August 2026https://greeksoup.ai/stocks/us/arwr/planned-sales/us:ARWR:planned-sale:2026-08-18:8a54b462feTue, 18 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Arrowhead Pharmaceuticals, Inc.: Form 144, Michael Perry plans to sell 11,600 shares worth $1.0 million around 18 August 2026https://greeksoup.ai/stocks/us/arwr/planned-sales/us:ARWR:planned-sale:2026-08-18:f8df2c40a8Tue, 18 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Arrowhead Pharmaceuticals, Inc.: Schedule 13G/A filed by Avoro Capital Advisors LLC, 9.6% of the classhttps://greeksoup.ai/stocks/us/arwr/holders/us:ARWR:schedule-13:2026-08-14:2ba60b6d53Fri, 14 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Arrowhead Pharmaceuticals, Inc.: short interest 9,207,426 shares at the 14 August 2026 settlement, 7.81 days to coverhttps://greeksoup.ai/stocks/us/arwr/short-interest/us:ARWR:short-interest:2026-08-14:288c8a3e0fFri, 14 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Arrowhead Pharmaceuticals, Inc. Q3 FY2026 results: revenue $75 million, net income -$194 millionhttps://greeksoup.ai/stocks/us/arwr/results/fy2026-q3/us:ARWR:result:2026-08-04:d35e32f811Tue, 04 Aug 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> Arrowhead Pharmaceuticals, Inc. filed 8-K: results of operationshttps://greeksoup.ai/stocks/us/arwr/filings/us:ARWR:filing:2026-08-04:bdb3a9c04eTue, 04 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Arrowhead Pharmaceuticals, Inc. filed 10-Q: 10-qhttps://greeksoup.ai/stocks/us/arwr/filings/us:ARWR:filing:2026-08-04:237df274d6Tue, 04 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Arrowhead Pharmaceuticals, Inc.: Schedule 13G/A filed by Vanguard Portfolio Management, 4.5% of the classhttps://greeksoup.ai/stocks/us/arwr/holders/us:ARWR:schedule-13:2026-07-31:f32978336dFri, 31 Jul 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Arrowhead Pharmaceuticals, Inc.: short interest 9,656,078 shares at the 31 July 2026 settlement, 3.85 days to coverhttps://greeksoup.ai/stocks/us/arwr/short-interest/us:ARWR:short-interest:2026-07-31:74920125b3Fri, 31 Jul 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Arrowhead Pharmaceuticals, Inc.: Schedule 13G/A filed by BlackRock, Inc., 10.1% of the classhttps://greeksoup.ai/stocks/us/arwr/holders/us:ARWR:schedule-13:2026-07-27:594177f87dMon, 27 Jul 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Arrowhead Pharmaceuticals, Inc.: short interest 9,635,297 shares at the 15 July 2026 settlement, 4.86 days to coverhttps://greeksoup.ai/stocks/us/arwr/short-interest/us:ARWR:short-interest:2026-07-15:aefb900576Wed, 15 Jul 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]>